Mentor Injects Dermal Filler Pipeline With Genzyme R&D

Mentor will market future Genzyme-developed hyaluronic acid dermal filler products to complement its existing Puragen hyaluronic acid device platform under a partnership agreement announced Oct. 30

More from Archive

More from Medtech Insight